Clinical trial · Observational
Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.
Behavioral Economics Study of Individual Factors Influencing Time-to-care Among Women With Invasive Breast Cancer in the Hauts-de-France Region
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Women in the Hauts-de-France region show higher breast cancer mortality despite no overall higher incidence, suggesting differences in the care pathway. This multicenter study will describe the overall time from the first warning sign to initiation of the first treatment, and will break down this delay into three consecutive intervals (symptoms to mammography, mammography to biopsy, biopsy to first treatment). Participants will complete a one-time questionnaire (up to 1 hour, with assistance if needed), and clinical data will be extracted in a standardized way from medical records (key dates and tumor characteristics). A random sample of 10% of incident breast cancer cases identified by each hospital information department will be used to ensure balanced geographic representation across 38 centers. The study will also explore how individual and contextual factors (psychological, behavioral, socio-demographic, access to care, communication) are associated with each time interval, and exploratory analyses will assess links with severity (metastases and prognostic score).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Invasive Breast Carcinoma | Invasive Breast Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Total time from first warning sign to initiation of first treatment.
- timeFrame
- One-time assessment using patient-reported dates and medical record dates at inclusion (single questionnaire session + record extraction). Questionnaire time : around 1 hour
Secondary outcomes (5)
- measure
- Time from first warning sign to first mammography
- timeFrame
- At inclusion, one-time assessment using patient-reported dates and medical record dates.
- measure
- Time from mammography to biopsy.
- timeFrame
- At inclusion, one-time assessment using patient-reported dates and medical record dates.
- measure
- Time from biopsy to initiation of first treatment.
- timeFrame
- At inclusion, one-time assessment using patient-reported dates and medical record dates.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female, age ≥ 18 years. * Confirmed invasive breast carcinoma. * Diagnosis in 2024 (and/or \< 12 months at inclusion depending on center organization). * Affiliated with the French social security system. * Resident of Hauts-de-France since diagnosis. * Information provided and non-opposition documented (MR-003). Exclusion Criteria: * Male breast cancer. * Other histologies (phyllodes tumor, sarcoma, lymphoma). * Pure ductal carcinoma in situ (in situ only). * Personal history of breast cancer (including in situ). * Non-French-speaking. * Person deprived of liberty.
References
Publications (0)
Data not yet available